Atria’s start ups
The best way to predict the future is to create it
Atria Startups is a division of our holding company that focuses on innovative solutions in the global Internet, software, consumer, financial, and agricultural technology.
After our top business team members thoroughly research a project, we focus on generating world-class investment returns over the long term. As we build a unique, global investment platform with every new project, we hope to do so in a way that will make our partners and portfolio companies proud.
Our top startup portfolio:
Abdulaziz Jouf founded the company "paytabs" in 2013 and currently serves as its CEO. Paytabs is one of the most secure and reliable online payment gateways. We chose to invest in Paytabs shares because our company is always striving to be at the forefront and best in all fields.
The company distinguishes itself by providing its customers with the best and most convenient payment methods and by providing guarantees to institutions and businesses looking to increase their revenue flow. PayTabs has been rapidly expanding across the globe since 2014, and they have proven to be a game changer in the global payments space.
PayTabs takes pride in providing electronic invoicing services to entrepreneurs and businesses, allowing them to save time and enjoy added convenience through paperless invoicing.
We want to advance and expand in agriculture, and our company owns hundreds of acres. These lands will be used for interests in the future to increase our profits. It is worth noting that there are approximately 200 dunams planted with palm trees among these dunams. We sell dates in a variety of countries.
Our cannabis factory, which will be operational soon, is one of our investments. Materials are extracted from the cannabis herb in our factory, which helps to overcome diseases and relieve pain, including relieving the pain of cancer, epilepsy, and arthritis, as well as protecting against cancer, diabetes, and Alzheimer's, among many other benefits. Our factory also conducts research to investigate new treatments.
